Internal Medicine, Hematology & Oncology · Huntersville, NC
NPI
1669876447
Since 2014
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
9930 Kincey Ave Ste 165
Huntersville, NC, 28078
Phone (704) 947-5005
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.7M
95,777 services
Medicare patients, 2024
297
Average age 75
Drug cost, 2024
$3.1M
1,094 prescriptions
Company payments, 2025
$2,347
From 36 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Poras K Patel was code J1439 (injection, ferric carboxymaltose, 1 mg), 18,753 times for 18 patients. In total Poras K Patel billed 95,777 services in 129 codes, and Medicare paid $1.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 18,753 | 18 | $0.87 | $16K |
| J0897 Injection, denosumab, 1 mg | Office | 3,723 | 22 | $20.69 | $77K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,198 | 69 | $0.09 | $196 |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 1,600 | 15 | $15.08 | $24K |
| 85025 Blood Count | Office | 846 | 244 | $7.55 | $6,385 |
| 80053 Clinical Chemistry | Office | 789 | 233 | $10.32 | $8,146 |
| 96367 Intravenous Infusion, Hydration | Office | 627 | 73 | $21.84 | $14K |
| 36415 Venipuncture Blood Collection | Office | 615 | 223 | $7.64 | $4,699 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 523 | 14 | $0.70 | $364 |
| 83615 Clinical Chemistry | Office | 475 | 163 | $5.90 | $2,804 |
| 82784 Immunoassay | Office | 363 | 57 | $9.04 | $3,283 |
| 99215 Office E&M - Established | Office | 359 | 74 | $140.93 | $51K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 356 | 11 | $0.07 | $26.28 |
| 99214 Office E&M - Established | Office | 351 | 162 | $88.77 | $31K |
| 82728 Clinical Chemistry | Office | 302 | 167 | $13.32 | $4,022 |
By year: 2022 $865K for 45,174 services; 2023 $918K for 45,286 services; 2024 $1.7M for 95,777 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 846 | 244 | $7.55 | $6,385 |
| 80053 Clinical Chemistry | 789 | 233 | $10.32 | $8,146 |
| 36415 Venipuncture Blood Collection | 615 | 223 | $7.64 | $4,699 |
| 83615 Clinical Chemistry | 475 | 163 | $5.90 | $2,804 |
| 82784 Immunoassay | 363 | 57 | $9.04 | $3,283 |
| 82728 Clinical Chemistry | 302 | 167 | $13.32 | $4,022 |
| 83550 Clinical Chemistry | 290 | 163 | $8.54 | $2,477 |
| 83540 Clinical Chemistry | 260 | 153 | $6.32 | $1,642 |
| 83735 Clinical Chemistry | 228 | 43 | $6.51 | $1,485 |
| 82607 Clinical Chemistry | 202 | 133 | $14.78 | $2,986 |
Medicare prescription drug claims, 2024
In 2024, the drug Poras K Patel prescribed most often to Medicare patients was Procrit (Epoetin Alfa), with 67 prescriptions and refills. In total Poras K Patel wrote 1,094 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Procrit Epoetin Alfa | 67 | 67 | 11 | $63K |
| Eliquis Apixaban | 64 | 94 | 20 | $56K |
| Letrozole Generic | 39 | 117 | 13 | $736 |
| Palonosetron Hcl Generic | 32 | 32 | Under 11 | $1,245 |
| Prolia Denosumab | 27 | 162 | 15 | $46K |
| Dexamethasone Generic | 26 | 29 | 12 | $377 |
| Abiraterone Acetate Generic | 25 | 25 | Under 11 | $98K |
| Cinvanti Aprepitant | 22 | 22 | Under 11 | $10K |
| Mvasi Bevacizumab-Awwb | 22 | 22 | Under 11 | $103K |
| Udenyca Autoinjector Pegfilgrastim-Cbqv | 21 | 21 | Under 11 | $122K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 21 | 21 | Under 11 | $381 |
| Duloxetine Hcl Generic | 20 | 35 | Under 11 | $209 |
| Xtandi Enzalutamide | 20 | 26 | Under 11 | $273K |
| Ruxience Rituximab-Pvvr | 18 | 25 | Under 11 | $106K |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 18 | 18 | Under 11 | $157K |
Brand drugs: 486 claims; generic drugs: 608 claims; opioid claims: 64.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Poras K Patel $2,347 ($2,347 in general payments such as food, travel and fees) from 36 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $231.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 13 | $231 |
| Pfizer Inc. PFE | 10 | $203 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $189 |
| GlaxoSmithKline, LLC. GSK | 5 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $117 |
| Array Biopharma Inc PFE | 6 | $113 |
| Janssen Biotech, Inc. JNJ | 5 | $109 |
| PharmaEssentia USA Corporation 6446.TW | 4 | $108 |
| Astellas Pharma US Inc 4503.T | 4 | $93.55 |
| Merck Sharp & Dohme LLC MRK | 3 | $82.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.